Quick Answer
Niagen Bioscience, Inc. reported Common Stock Shares Outstanding of 79.71 million shares for the year ending 2025.
- Niagen Bioscience, Inc. showed an increase of +3.1% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Niagen Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), Niagen Bioscience, Inc.'s Common Stock Shares Outstanding has grown by 30.9%.
- Historical annual values: Fiscal year 2025: 79.71 million shares | Fiscal year 2024: 77.33 million shares | Fiscal year 2023: 74.98 million shares | Fiscal year 2022: 74.57 million shares | Fiscal year 2021: 68.13 million shares | Fiscal year 2020: 61.88 million shares | Fiscal year 2019: 59.56 million shares | Fiscal year 2018: 55,089 shares | Fiscal year 2017: 54.70 million shares | Fiscal year 2016: 37.54 million shares | Fiscal year 2015: 36.00 million shares | Fiscal year 2014: 105.27 million shares | Fiscal year 2013: 104.52 million shares | Fiscal year 2012: 92.14 million shares | Fiscal year 2011: 72.94 million shares | Fiscal year 2010: 60.88 million shares.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: